Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 27,509 | 27,435 | 11,043 | 6,576 | 7,804 |
| Cost of Goods | 10,559 | 11,840 | 6,744 | 2,951 | N/A |
| Gross Profit | 16,950 | 15,595 | 4,299 | 3,625 | 7,804 |
| Operating Expenses | 64,048 | 62,920 | 40,417 | 20,937 | 123,573 |
| Operating Income | -46,539 | -46,485 | -35,374 | -16,361 | -115,769 |
| Interest Expense | 3,105 | 1,955 | 1,369 | 690 | 0 |
| Other Income | 1,944 | -7 | -2,201 | -954 | 1,990 |
| Pre-tax Income | -47,700 | -48,447 | -38,944 | -18,005 | -113,779 |
| Income Tax | 24 | 24 | 14 | 5 | -486 |
| Net Income Continuous | -47,724 | -48,471 | -38,958 | -18,010 | -113,293 |
| Net Income | $-47,724 | $-48,471 | $-38,958 | $-18,010 | $-113,293 |
| EPS Basic Total Ops | -29.50 | -29.68 | -38.49 | -64.75 | -2.20 |
| EPS Basic Continuous Ops | -28.76 | -29.59 | -38.45 | -64.76 | -2.20 |
| EPS Diluted Total Ops | -29.50 | -29.68 | -38.49 | -64.75 | -2.20 |
| EPS Diluted Continuous Ops | -28.76 | -29.59 | -38.45 | -64.76 | -2.20 |
| EPS Diluted Before Non-Recurring Items | -22.66 | -29.68 | -37.95 | N/A | -1.84 |
| EBITDA(a) | $-30,283 | $-43,128 | $-33,320 | $-14,617 | $-111,037 |